Brings over 35 years of oncology drug development experience, including senior executive leadership roles at AstraZeneca and Daiichi Sankyo Led the development and approval of multiple breakthrough medicines such as ENHERTU®, TAGRISSO®, and LYNPARZA® Strengthens Ona's transition to a...
Hence then, the article about ona therapeutics appoints oncology drug development veteran dr antoine yver as chair to accelerate adc programs to clinical inflection points was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ona Therapeutics Appoints Oncology Drug Development Veteran Dr. Antoine Yver as Chair to Accelerate ADC Programs to Clinical Inflection Points )
Also on site :
- Marshals Episode 9 Ends With Chilling Warning From Kayce's Nemesis: 'Like The Duttons, My Legacy Is Growing'
- Oil prices rise higher amid stalled US-Iran peace talks
- King Charles Was Almost 'Married Off' to This President's Daughter During His 1st US Visit in 1970